BOT 0.00% 37.0¢ botanix pharmaceuticals ltd

FYI....Kaken are currently in Phase 1 development stage for...

  1. 558 Posts.
    lightbulb Created with Sketch. 130
    FYI....
    Kaken are currently in Phase 1 development stage for Primary palmoplantar hyperhidrosis.
    This is seen as giving an additional indication to their Ecclock product. BOT's Sofdra.....
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.